These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 25561484)
1. Can psychedelic compounds play a part in drug dependence therapy? Sessa B; Johnson MW Br J Psychiatry; 2015 Jan; 206(1):1-3. PubMed ID: 25561484 [TBL] [Abstract][Full Text] [Related]
2. Analysis of recreational psychedelic substance use experiences classified by substance. Hase A; Erdmann M; Limbach V; Hasler G Psychopharmacology (Berl); 2022 Feb; 239(2):643-659. PubMed ID: 35031816 [TBL] [Abstract][Full Text] [Related]
3. A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. Chi T; Gold JA J Neurol Sci; 2020 Apr; 411():116715. PubMed ID: 32044687 [TBL] [Abstract][Full Text] [Related]
5. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078 [TBL] [Abstract][Full Text] [Related]
6. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics. Tófoli LF; de Araujo DB Int Rev Neurobiol; 2016; 129():157-85. PubMed ID: 27503452 [TBL] [Abstract][Full Text] [Related]
7. [Classic psychedelic drugs and their potential therapeutic effect]. Bayat M Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918777 [TBL] [Abstract][Full Text] [Related]
8. Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives. Cox DJ; Garcia-Romeu A; Johnson MW Am J Drug Alcohol Abuse; 2021 Jul; 47(4):444-454. PubMed ID: 34096403 [No Abstract] [Full Text] [Related]
9. Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence--qualitative results. Loizaga-Velder A; Verres R J Psychoactive Drugs; 2014; 46(1):63-72. PubMed ID: 24830187 [TBL] [Abstract][Full Text] [Related]
10. Psychedelic Medicines in Major Depression: Progress and Future Challenges. Bouso JC; Ona G; Dos Santos RG; Hallak JEC Adv Exp Med Biol; 2021; 1305():515-533. PubMed ID: 33834416 [TBL] [Abstract][Full Text] [Related]
11. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Carhart-Harris RL; Goodwin GM Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. Breeksema JJ; Niemeijer AR; Krediet E; Vermetten E; Schoevers RA CNS Drugs; 2020 Sep; 34(9):925-946. PubMed ID: 32803732 [TBL] [Abstract][Full Text] [Related]
15. Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Bogenschutz MP Curr Drug Abuse Rev; 2013 Mar; 6(1):17-29. PubMed ID: 23627783 [TBL] [Abstract][Full Text] [Related]
16. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy. Mash DC Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284 [TBL] [Abstract][Full Text] [Related]
17. Treating drug dependence with the aid of ibogaine: a retrospective study. Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214 [TBL] [Abstract][Full Text] [Related]
18. The renaissance in psychedelic research: What do preclinical models have to offer. Murnane KS Prog Brain Res; 2018; 242():25-67. PubMed ID: 30471682 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Applications of Classic Hallucinogens. Bogenschutz MP; Ross S Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684 [TBL] [Abstract][Full Text] [Related]